Altimmune, Inc. (ALT) Social Stream



Altimmune, Inc. (ALT): $12.09

0.01 (-0.08%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add ALT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#298 of 360

in industry

ALTIMMUNE INC (ALT) Price Targets From Analysts

Use the tables below to see what analysts covering ALTIMMUNE INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 6 $36 $25 $29.714 $11.72 153.53%
2022-01-10 6 $36 $25 $30.5 $11.72 160.24%
2022-01-31 6 $34 $21 $28.2 $11.72 140.61%
2022-05-17 5 $34 $21 $28.2 $11.72 140.61%
2022-06-01 5 $31 $21 $26.4 $11.72 125.26%
2022-08-03 4 $30 $21 $25.25 $11.72 115.44%
2022-08-12 4 $30 $25 $26.5 $11.72 126.11%
2022-08-17 4 $50 $25 $32.75 $11.72 179.44%
2022-08-31 4 $50 $25 $34 $11.72 190.1%
2022-10-02 5 $50 $25 $32.4 $11.72 176.45%
2022-11-21 6 $50 $25 $31.333 $11.72 167.35%
2023-03-22 7 $50 $20 $29.714 $11.72 153.53%
2023-05-15 7 $50 $6 $26.142 $11.72 123.05%
2023-06-27 7 $50 $6 $25.571 $11.72 118.18%
2023-08-10 7 $50 $6 $25.285 $11.72 115.74%
2023-08-11 7 $50 $6 $24.571 $11.72 109.65%
2023-11-07 6 $35 $6 $18.5 $11.72 57.85%
2023-11-09 7 $35 $6 $17.571 $11.72 49.92%
2023-12-04 7 $35 $6 $18.571 $11.72 58.46%
2023-12-06 7 $35 $6 $19.571 $11.72 66.99%

The Trend in the Analyst Price Target


ALT's average price target has moved down $10.14 over the prior 43 weeks.

ALT reports an average of 459.9% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-21 7 50 20 29.714 11.33 162.26%
2023-03-09 7 50 20 29.714 11.37 161.34%
2023-03-22 7 50 20 29.714 4.20 607.48%
2023-08-14 7 35 6 19.571 2.98 556.74%
2023-08-14 6 35 6 18.500 2.98 520.81%

ALT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


Over the past 30 months, ALT's average broker recommendation rating improved by 0.38.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ALT has a lower variance in analysts' estimates than -1775.38% of all US stocks.
  • ALT has a greater upside potential (average analyst target price relative to current price) than 2013.35% of all US stocks.
  • In the context of stocks in the small market cap category, ALTIMMUNE INC's number of analysts covering the stock is greater than 1667.74% of them.
  • ALT has a higher average analyst price target than 1640.16% of stocks in the small market cap category.

In the Pharmaceutical Products industry, MNOV, SVRA, and BPTH are the three stocks most similar to ALTIMMUNE INC regarding the price target and analyst recommendation information presented here.

Is ALT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!